Geode Capital Management
KRMD icon

Geode Capital Management’s KORU Medical Systems KRMD Stock Holding History

Geode Capital Management’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.05M Sell
1,040,708
-87,388
-8% -$316K ﹤0.01% 3060
2026
Q2 		$4.74M Buy
1,128,096
+76,888
+7% +$315K ﹤0.01% 2945
2026
Q1 		$4.54M Buy
1,051,208
+28,348
+3% +$141K ﹤0.01% 2786
2025
Q4 		$5.94M Buy
1,022,860
+16,062
+2% +$76.9K ﹤0.01% 2680
2025
Q3 		$3.86M Buy
1,006,798
+9,651
+1% +$36.9K ﹤0.01% 2914
2025
Q2 		$3.57M Buy
997,147
+501,875
+101% +$1.43M ﹤0.01% 2901
2025
Q1 		$1.26M Buy
495,272
+32,094
+7% +$119K ﹤0.01% 3224
2024
Q4 		$1.78M Buy
463,178
+1,050
+0.2% +$3.41K ﹤0.01% 3173
2024
Q3 		$1.26M Buy
462,128
+28,323
+7% +$69.8K ﹤0.01% 3277
2024
Q2 		$1.15M Sell
433,805
-332,367
-43% -$760K ﹤0.01% 3256
2024
Q1 		$1.81M Buy
766,172
+4,688
+0.6% +$10.1K ﹤0.01% 3149
2023
Q4 		$1.87M Buy
761,484
+24,602
+3% +$58.6K ﹤0.01% 3128
2023
Q3 		$1.99M Buy
736,882
+25,239
+4% +$69.1K ﹤0.01% 3078
2023
Q2 		$2.46M Buy
711,643
+372,628
+110% +$1.46M ﹤0.01% 3048
2023
Q1 		$1.43M Hold
339,015
– – ﹤0.01% 3173
2022
Q4 		$1.21M Buy
339,015
+3,378
+1% +$9.31K ﹤0.01% 3267
2022
Q3 		$748K Buy
335,637
+36,446
+12% +$90.2K ﹤0.01% 3534
2022
Q2 		$756K Sell
299,191
-23,385
-7% -$56.8K ﹤0.01% 3543
2022
Q1 		$922K Buy
322,576
+6,252
+2% +$18.7K ﹤0.01% 3655
2021
Q4 		$948K Buy
316,324
+45,856
+17% +$141K ﹤0.01% 3749
2021
Q3 		$770K Sell
270,468
-288
-0.1% -$953 ﹤0.01% 3820
2021
Q2 		$1.25M Sell
270,756
-182,190
-40% -$715K ﹤0.01% 3483
2021
Q1 		$1.59M Buy
452,946
+77,775
+21% +$337K ﹤0.01% 3368
2020
Q4 		$2.26M Buy
375,171
+27,800
+8% +$156K ﹤0.01% 3017
2020
Q3 		$2.51M Buy
347,371
+31,754
+10% +$282K ﹤0.01% 2760
2020
Q2 		$2.83M Buy
315,617
+156,712
+99% +$1.58M ﹤0.01% 2652
2020
Q1 		$1.19M Buy
158,905
+45,984
+41% +$309K ﹤0.01% 2940
2019
Q4 		$737K Buy
+112,921
New +$551K ﹤0.01% 3380

Other funds holding KRMD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
SC
Simcoe Capital Spokane, Washington $146M AUM 53.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
White Pine Capital
White Pine Capital Bloomington, Minnesota $419M AUM 48.71% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Geode Capital Management's KRMD Position: Q3 2026 in Review

Geode Capital Management reduced its KORU Medical Systems (KRMD) stake by 7.7% in Q3 2026, selling an estimated $316K and leaving 1,040,708 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3060.

Geode Capital Management first reported a position in KRMD in Q4 2019 and has held it in 28 quarters since. The position peaked at $5.94M in Q4 2025. 59 funds tracked by Wall St. Rank hold KRMD as of Q3 2026.

  • Geode Capital Management held 1,040,708 shares of KORU Medical Systems worth $3.05M as of Q3 2026.
  • Geode Capital Management sold 87,388 KORU Medical Systems shares in Q3 2026, an estimated $316K.
  • KORU Medical Systems made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3060 holding.
  • Geode Capital Management first reported a position in KORU Medical Systems in Q4 2019 and has held it in 28 quarters since.
  • Geode Capital Management's KORU Medical Systems position peaked at $5.94M in Q4 2025.
  • 59 funds tracked by Wall St. Rank held KORU Medical Systems as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.